Beckman Coulter Life Sciences has announced its acquisition of Cytobank, a privately held, single cell data analysis, software as a service (SaaS) company based in Santa Clara, California.

Cytobank provides an industry-leading, cloud and machine learning-based software platform for multi-parametric single-cell data analysis, sharing and archiving. The platform accelerates research productivity by enabling efficient high-dimensional multi-omics data analysis, visualization and collaboration across multiple sites.

The technology pairs naturally with Beckman Coulter Life Sciences' CytoFLEX LX 21-color flow cytometer to meet the growing high-complexity workflow and data analysis needs of basic and clinical research scientists.

Cytobank will transition into Beckman Coulter Life Sciences under the Danaher Life Sciences platform, which generated approximately $6.5 billion in revenue during 2018.